Physical activity and modulation of systemic low-level inflammation

Altering any health behaviors leads to a reduction in the risk factors for preventable non-communicable diseases.

“Even if it is well understood that altering any health behaviors leads to a reduction in the risk factors for preventable non-communicable diseases [18,20,26-33].”

Improvements from altering health behaviors appear to stem from endocrinological changes that occur with overfatness and following exposure to exercise.

“Where these improvements appear to stem from a number of endocrinological changes that occur with both expression of overfatness and following exposure to exercise that ultimately alters the health status for the individual who is overfat [18,19,26,28,30,32-34].”

Low utilization of healthy behaviors elicits changes that increase risk for metabolic issues, which may culminate in Type 2 Diabetes Mellitus, and are associated with reduced work capacity and anabolic hormone response in overfat individuals.

“With low utilization of healthy behaviors eliciting changes indicated to increase the risk for the development of metabolic issues, which may culminate in Type 2 Diabetes Mellitus (T2DM), and are readily associated with reduced work capacity and anabolic hormone response for the individual who is overfat [18,26,27].”

Changes in humoral factors are necessary for improvement in health status.

“The changes elicited in humoral factors (e.g., hormone/cytokines, blood lipids and biomarkers of inflammation) are necessary for improvement in health status that many have previously discussed in a number of reviews on this topic [18-21,26,31,32,34,42].”

Any treatment produces effective change toward normal healthy range, leading to reduced CVD risk and improved health.

“any treatment is able to produce an effective change that leads toward a normal “healthy” range, thus leading to a reduced risk for development of cardiovascular disease and improvements in work capacity and overall health”

Chronic low-grade systemic inflammation is characterized by a 2- to 3-fold elevation in systemic concentrations of proinflammatory and anti-inflammatory cytokines, natural occurring cytokine antagonists, and C-reactive protein.

“Chronic low-grade systemic inflammation has been characterized by a 2- to 3-fold elevation in the systemic concentrations of proinflammatory and anti-inflammatory cytokines, natural occurring cytokine antagonists, and the acute phase reactant C-reactive protein (CRP) [13, 22].”